FDA To Decide By June 15th Fate Of First-Ever HIV Prevention Drug
The FDA is expected to decide by June 15, 2012 whether the first-ever HIV prevention drug will be approved after the FDA Antiviral Drugs Advisory Committee voted overwhelmingly on May 10, 2012 in favor of Truvada PrEP (emtricitabine/tenofovir disoproxil fumarate) for HIV-uninfected men who have sex[...]